Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment;Farnier;Am J Cardiol,1998
2. Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolemia: a multinational, randomised, double-blind study. Cerivastatin StudyG Group;Ose;Curr Med Res Opin,1999
3. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study G Group;Insull;J Int Med Res,2000
4. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group;Dujovne;Mayo Clin Proc,2000
5. Les études citées et leurs références peuvent être consultées dans : Haïat R, Leroy G. Prescriptions et recommandations en cardiologie. 6e édition, Frison-Roche Ed Paris. (sous presse)